In 2023, French pharmaceutical and healthcare company Sanofi generated approximately 38 billion euros through its biopharmaceutical segment. Sanofi’s consumer healthcare segment earned the company about 5.2 billion euros in that year.
Sanofi’s top products
Sanofi develops various pharmaceutical products, including Aubagio, Lovenox, and Dupixent. One of the company’s top products based on revenue is also Lantus. In 2023, this long-acting insulin used to treat diabetes, generated some 1.4 billion euros. Aubagio earned the company roughly one billion euros within the same year.
Top U.S. drugs
Based on sales numbers over the last years, Humira is by far the top prescription drug in the United States. Before 2023, the drug generated around 20 billion U.S. dollars in the United States per year. Among the country’s most prescribed medicines, however, are atorvastatin, lisinopril, and levothyroxine.
Revenue of Sanofi by segment from 2014 to 2023
(in million euros)
* From 2023 on called "Biopharma" ("Pharmaceuticals" + "Vaccines").
** During 2016, the Animal Health and the Consumer Healthcare segments were the objects of a swap deal between Sanofi and Boehringer Ingelheim. Since 2016, Animal Health revenues were no longer part of Sanofi's total revenues.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Sanofi. (February 23, 2024). Revenue of Sanofi by segment from 2014 to 2023 (in million euros) [Graph]. In Statista. Retrieved December 19, 2024, from https://www.statista.com/statistics/266504/sanofi-aventis-revenue-by-product/
Sanofi. "Revenue of Sanofi by segment from 2014 to 2023 (in million euros)." Chart. February 23, 2024. Statista. Accessed December 19, 2024. https://www.statista.com/statistics/266504/sanofi-aventis-revenue-by-product/
Sanofi. (2024). Revenue of Sanofi by segment from 2014 to 2023 (in million euros). Statista. Statista Inc.. Accessed: December 19, 2024. https://www.statista.com/statistics/266504/sanofi-aventis-revenue-by-product/
Sanofi. "Revenue of Sanofi by Segment from 2014 to 2023 (in Million Euros)." Statista, Statista Inc., 23 Feb 2024, https://www.statista.com/statistics/266504/sanofi-aventis-revenue-by-product/
Sanofi, Revenue of Sanofi by segment from 2014 to 2023 (in million euros) Statista, https://www.statista.com/statistics/266504/sanofi-aventis-revenue-by-product/ (last visited December 19, 2024)
Revenue of Sanofi by segment from 2014 to 2023 (in million euros) [Graph], Sanofi, February 23, 2024. [Online]. Available: https://www.statista.com/statistics/266504/sanofi-aventis-revenue-by-product/
